Registered entities
Exelixis, Inc.
Reg. No. 43257395United States
Exelixis Inc
Reg. No. 0745.964.741Belgium
Exel Stocks Inc.
Reg. No. 1470302United States
EXEL INC.
Reg. No. 42801160United States
Innovation
319 patent families (149 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace steady. Cited 19,438 times.
| Year | Filings |
|---|---|
| 2015 | 43 |
| 2016 | 45 |
| 2017 | 41 |
| 2018 | 32 |
| 2019 | 41 |
| 2020 | 36 |
| 2021 | 39 |
| 2022 | 40 |
| 2023 | 45 |
| 2024 | 45 |
| 2025 | 55 |
| 2026 | 19 |
Social engagement
Social engagement: 68.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 40% |
| Private equity | 4 | 27% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 4 | 27% |
Hiring activity
Hires frequently
45 roles tracked across 8 of the last 12 months
10 Jun 2026 · Compliance QA Director · Alameda
19 May 2026 · Senior Oncology Account Manager (Remote - San Jose, CA) · San Jose
11 May 2026 · Statistical Programming Manager · Alameda
20 Apr 2026 · Compliance Operations Manager · Alameda
14 Apr 2026 · Associate Clinical Data Management Director · Alameda
Based on job postings tracked across public sources.
Recent activity
4 Jun 2026
Recognition
29 May 2026
Event
ASCO26